Company: ABBV
Filing Date: 2025-03-10
Form Type: PRE 14A
Source: 0001558370-25-002603
Chunk: 48

Company: AbbVie Inc.
Filing Date: 2025-03-10
Form: PRE 14A
Chunk 48
---
 / $(263,944); A. Saleki-Gerhardt: $76,048 / $190,794 / $(202,627); and T. Richmond $36,076. AbbVie Supplemental Pension Plan R. Michael: $1,669,967 / $2,776,666 / $(1,162,821); R. Gonzalez: $(1,228,397) / $(154,979) / $(3,814,003); S. Reents: $1,479,025 / $1,627,895 / $893,948; J. Stewart: $1,682,840 / $4,918,891 / $(1,248,100); A. Saleki-Gerhardt: $(329,624) / $1,462,884 / $(1,289,139); and T. Richmond $708,718. The changes in pension value result primarily from the following factors: (i) the effect of changes in the actuarial assumptions AbbVie uses to calculate plan liability for financial reporting purposes; (ii) additional pension benefit accrual under the Pension Plan and the Supplemental Pension Plan; and (iii) the impact of the time value of money on the pension value. Non-Qualified Defined Contribution Plan Earnings The totals in this column include reportable interest credited under the AbbVie Performance Incentive Plan and the AbbVie Supplemental Savings Plan. R. Michael: $335,617 / $123,213 / $1,607; R. Gonzalez: $1,863,298 / $1,331,617 / $439,214; S. Reents: $500,198 / $294,882 / $79,768; J. Stewart: $939,164 / $594,880 / $179,792; A. Saleki-Gerhardt: $1,052,397 / $707,787 / $223,236; and T. Richmond: $966,974.

| (5) | The amounts shown in this column include the change in pension value during the applicable year, which is attributable to changes in actuarial assumptions (primarily discount rate and mortality tables) and other factors based on plan design (primarily pay, service and age). |

The present value of a pension benefit is determined, in part, by the discount rate used for accounting purposes. The discount rate is determined by reference to the prevailing market rate of interest. In 2024, interest rates